nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity
|
Fujiwara, Hiroshi |
|
|
29 |
10 |
p. 1574-1585 |
artikel |
2 |
A phase 2 study of mobocertinib as first-line treatment in Japanese patients with non-small cell lung cancer harboring EGFR exon 20 insertion mutations
|
Yoh, Kiyotaka |
|
|
29 |
10 |
p. 1461-1474 |
artikel |
3 |
A retrospective study of prognostic factors and prostate-specific antigen dynamics in Japanese patients with metastatic hormone-sensitive prostate cancer who received combined androgen blockade therapy with bicalutamide
|
Tashiro, Yu |
|
|
29 |
10 |
p. 1564-1573 |
artikel |
4 |
Association between hospital palliative care team intervention volume and patient outcomes
|
Abe, Hiroaki |
|
|
29 |
10 |
p. 1602-1609 |
artikel |
5 |
Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer
|
Onaga, Ryutaro |
|
|
29 |
10 |
p. 1435-1443 |
artikel |
6 |
Comparative analysis of dual immune checkpoint inhibitor combination therapy versus immune checkpoint inhibitor plus tyrosine kinase inhibitor combination therapy for renal cell carcinoma with inferior vena cava tumor thrombosis
|
Yoshida, Kazuhiko |
|
|
29 |
10 |
p. 1538-1547 |
artikel |
7 |
Correction to: Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan
|
Yamaguchi, Tatsuro |
|
|
29 |
10 |
p. 1432-1434 |
artikel |
8 |
Correction to: Real‑world practice of estrogen therapy after surgery for endometrial cancer: a descriptive study using a Japanese claims database
|
Inayama, Yoshihide |
|
|
29 |
10 |
p. 1610-1613 |
artikel |
9 |
Efficacy of robot-assisted partial nephrectomy compared to conventional laparoscopic partial nephrectomy for completely endophytic renal tumor: a multicenter, prospective study
|
Hinata, Nobuyuki |
|
|
29 |
10 |
p. 1548-1556 |
artikel |
10 |
Endoscopic and exoscopic surgery for brain tumors
|
Sasagawa, Yasuo |
|
|
29 |
10 |
p. 1399-1406 |
artikel |
11 |
Endoscopic ultrasound-guided hepaticogastrostomy vs. antegrade metal stent placement keeping an access route in patients with malignant biliary obstruction
|
Itonaga, Masahiro |
|
|
29 |
10 |
p. 1500-1508 |
artikel |
12 |
Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan
|
Yamaguchi, Tatsuro |
|
|
29 |
10 |
p. 1417-1431 |
artikel |
13 |
Genomic medicine advances for brain tumors
|
Koizumi, Shinichiro |
|
|
29 |
10 |
p. 1407-1416 |
artikel |
14 |
Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer
|
Tsukazaki, Yuki |
|
|
29 |
10 |
p. 1451-1460 |
artikel |
15 |
Impact of interstitial lung disease gender-age-physiology index in surgically treated lung cancer
|
Sakamoto, Shinichi |
|
|
29 |
10 |
p. 1475-1482 |
artikel |
16 |
Long-term consequences of positive surgical margin after partial nephrectomy for renal cell carcinoma: multi‐institutional analysis
|
Hulin, Maud |
|
|
29 |
10 |
p. 1509-1515 |
artikel |
17 |
Long-term outcomes of the first prospective study of active surveillance for prostate cancer in Japan
|
Kato, Takuma |
|
|
29 |
10 |
p. 1557-1563 |
artikel |
18 |
Measurement of the distance between tumor micro-foci and gross tumor in rectal cancer pathological specimens: implication on margin distance of clinical target volume treated with high-dose radiotherapy for rectal cancer
|
Bao, Xu-Jie |
|
|
29 |
10 |
p. 1491-1499 |
artikel |
19 |
Phase 3 THOR Japanese subgroup analysis: erdafitinib in advanced or metastatic urothelial cancer and fibroblast growth factor receptor alterations
|
Matsubara, Nobuaki |
|
|
29 |
10 |
p. 1516-1527 |
artikel |
20 |
Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement
|
Tanegashima, Tokiyoshi |
|
|
29 |
10 |
p. 1586-1593 |
artikel |
21 |
Prognostic significance of inflammatory markers in patients with advanced renal cell carcinoma receiving nivolumab plus ipilimumab
|
Nakayama, Takayuki |
|
|
29 |
10 |
p. 1528-1537 |
artikel |
22 |
Prognostic value of pretreatment temporal muscle thickness after curative surgery for oral cavity squamous cell carcinoma
|
Mukai, Toshiyuki |
|
|
29 |
10 |
p. 1444-1450 |
artikel |
23 |
Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study
|
Nagao, Shoji |
|
|
29 |
10 |
p. 1594-1601 |
artikel |
24 |
Severe weight loss during PD-1 treatment is a risk sign of poor prognosis for advanced GC patients
|
Geng, Jun |
|
|
29 |
10 |
p. 1483-1490 |
artikel |